溶解性 | 25°C: DMSO |
存贮条件 | 储存温度-20°C |
生化机理 | Description: IC50 Value: 4 nM (IC50) for Aurora A, and below or equal to 13 nM (IC50) for Aurora B [1]. SCH 1473759, a novel sub-nanomolar Aurora A/B inhibitor. Aurora kinases are required for orderly progression of cells through mitosis, and inhibition of these kinases by siRNA or small molecule inhibitors results in cell death [2]. in vitro: Asynchronous cells required 24-h exposure to SCH 1473759 for maximal induction of >4 N DNA content and inhibition of cell growth. However, following taxane- or KSP inhibitor-induced mitotic arrest, less than 4-h exposure induced >4 N DNA content. This finding correlated with the ability of SCH 1473759 to accelerate exit from mitosis in response to taxane- and KSP inhibitor-induced arrest [2]. in vivo: SCH-1473759 showed efficacy and target engagement in A2780 human tumor xenograft model in mouse, and also acceptable pharmacokinetic dosing in dog, monkey and rodents, on target efficacy, as well as a safety profile in dogs[1]. Clinical trial: N/A |
SCH-1473759
SCH-1473759 (订货以英文为准)
编号:S127253
CAS号:1094069-99-4
分子式:C20H26N8OS
分子量:426.54
产品名称 | SCH-1473759 |
中文名称 | SCH-1473759 |
CAS号 | 1094069-99-4 |
分子式(M.F.) | C20H26N8OS |
分子量(M.W.) | 426.54 |
储存条件 | -20℃ |
搜索质检报告(COA)
搜索MSDS
相关产品